OptiBiotix appoints Martin Hunt chairman of subsidiary SkinBiotix
5th Oct 2016 11:43
(ShareCast News) - AIM-listed life science company OptiBiotix Health appointed industry veteran Martin Hunt chairman and director of its majority-owned subsidiary SkinBiotix. Hunt has experience in the life sciences sector from large multi-nationals to AIM-listed companies at MDY Healthcare, Videreg
Read moreOptiBiotix trumpets success of weight loss products
6th Sep 2016 08:58
(ShareCast News) - OptiBiotix Health, a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announced the results of an independent consumer survey of its GoFigure products on Tuesday. The AIM-traded firm said the products, in the form of meal rep
Read moreOptiBiotix Health reports wider first half loss
25th Aug 2016 12:26
(ShareCast News) - OptiBiotix Health's shares dropped on Thursday as the medical product developer reported a wider first half loss. In the six months to the end of May, the loss before tax widened to £713,772 from £514,424 the same period a year earlier as administrative expenses grew to £802,0
Read moreOptiBiotix Health snacks now available at UK Whole Foods
9th Aug 2016 14:42
(ShareCast News) - AIM-listed OptiBiotix Health said its GoFigure meal replacement shakes and natural snack bars are now available at Whole Foods Market stores in the UK. The life sciences company, which develops compounds to tackle obesity, high cholesterol and diabetes, said GoFigure products will
Read moreOptiBiotix appoints director of business development
2nd Aug 2016 13:37
(ShareCast News) - AIM-listed OptiBiotix Health has announced the appointment of Luis Gosalbez as director of business development with immediate effect. The company, which develops compounds to tackle obesity, high cholesterol, diabetes and skin care, said Gosalbez brings a strong scientific backgr
Read moreOptiBiotix launches healthy food range, buys majority of partner
26th Jul 2016 12:16
(ShareCast News) - Obesity, high cholesterol, diabetes and skin care focused life sciences company OptiBiotix Health announced on Tuesday the successful completion of a trial launch for its Slimbiome ingredients in a range of meal replacement shakes and natural snack bars. The AIM-traded firm also r
Read moreOptiBiotix raises £1m in new placing
5th Feb 2016 09:55
(ShareCast News) - OptiBiotix had an additional £1m to play with on Friday, announcing a new placing of 1,282,051 ordinary shares at 78p each. The AIM-traded life sciences company, which specialises in products treating obesity, high cholesterol and diabetes, said the placing shares were issued to f
Read moreSunday share tips: Britvic, Tungsten, Optibiotix
19th Jul 2015 17:49
(ShareCast News) - Shares in drinks maker and Wimbledon tennis sponsor Britvic are worth buying ahead of its third-quarter trading statement next Thursday, advised Questor in the Sunday Telegraph. The sunny weather in the UK and France should boost performance in the period, with analysts expecting
Read moreOptibiotex Health signs contract with Spanish research centre
9th Jul 2015 11:45
OptiBiotix Health, a life sciences business developing compounds to tackle obesity, has partnered with a research centre in Madrid to develop its technology platform. The company signed an agreement with the Instituto de Química Orgánica General, part of the Spanish National Research Council, which
Read moreOptiBiotex Health wins first contract for its cholesterol reducing product
2nd Jun 2015 11:15
Life sciences group OptiBiotix Health won a contract with a multinational consumer goods company to provide an option agreement for its cholesterol reducing product. The company did not disclose the name of the partner or any financial details as the terms of the agreement are confidential. OptiBio
Read more